Development of Preterm Infants Born During the COVID-19 Pandemic
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 5
SponsorFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
About this trial
This study aims to evaluate differences in cognitive and psychomotor development among preterm infants (born before 34 weeks of gestation) delivered during the COVID-19 pandemic at Hospital de la Santa Creu i Sant Pau, compared with a control group of preterm infants born at the same hospital.
Eligibility criteria
Qualifiers
Preterm babies (<34 weeks of gestation) born between March 2020 and December 2021 for case group).
Preterm babies (<34 weeks of gestation) born between January 2023 to December 2024 (control group).
Babies who were admitted to the NICU of the Hospital de Sant Pau.
Babies who were followed up in External Consultations of the same hospital at least until their first year of age.
Disqualifiers
Preterm infants ≥34 weeks or preterm born outside the periods described in the inclusion criteria.
Concurrent diagnosis of genetic pathology or major malformations.
Families who discontinued follow-up or did not attend scheduled appointments.
Trial design
Treatments tested in this trial
- Evaluation of cognitive and psychomotor development through the Bayley Scales Of Infant and Toddler Development and Wechsler Preschool and Primary Scale of Intelligence
Treatment groups
120 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov